Genetic Signatures Limited (ASX: GSS)
Australia
· Delayed Price · Currency is AUD 0.650
-0.030 (-4.41%)
Dec 4, 2024, 3:41 PM AEST
Genetic Signatures Market Cap
Genetic Signatures has a market cap or net worth of 154.41 million as of December 3, 2024. Its market cap has increased by 119.74% in one year.
Market Cap
154.41M
Enterprise Value
119.38M
Revenue
13.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.65
Market Cap Chart
Since March 31, 2015, Genetic Signatures's market cap has increased from 35.38M to 154.41M, an increase of 336.47%. That is a compound annual growth rate of 16.43%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 136.65B |
| ResMed Inc. | 56.11B |
| Pro Medicus Limited | 26.32B |
| Fisher & Paykel Healthcare Corporation Limited | 20.25B |
| Cochlear Limited | 19.91B |
| Sonic Healthcare Limited | 13.72B |
| Ramsay Health Care Limited | 9.08B |
| Telix Pharmaceuticals Limited | 8.28B |